请使用支持JavaScript的浏览器! 阳谷华泰:首次公开发行股票并在创业板上市招股说明书 ..._蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall -蚂蚁淘商城
当前位置: > 首页 > 技术文章 >
阳谷华泰:首次公开发行股票并在创业板上市招股说明书 ...
来自 : 蚂蚁淘

MATERIALS:

1.1XPBS(PBSAz,1XPBS,e.g.,IrvineScientific,CA,containing2%newborncalfserumand0.1%sodiumazide)

2.7-Amino-actinomycinD(7-AAD,e.g.,Calbiochem,CA)

3.HumanABserum,heat-inactivated(HAB,e.g.,IrvineScientific,CA)

4.Refrigeratedcentrifuge

Preparationof7-AADstocksolution

Dissolve7-AADpowder(1mg)firstin50microlitersofabsolutemethanol,thenadd950microlitersof1XPBS.Finalconcentrationis1mg/ml.Keepsolutionat4°Cprotectedfromlight.Solutioncanbestoredforatleastupto6months.

METHOD:

Principle:

Apoptoticcells,probablyduetoachangeinmembranepermeABIlity,takeupsome7-AADandbecome7-AADdimcomparedtolivecellswhichremain7-AAD-.Lateapoptoticornecroticcellswhichhavelostmembraneintegrityappear7-AADbright.

Reference:SchmidI,UittenbogaartCH,KeldB,andGiorgiJV:Arapidmethodformeasuringapoptosisanddual-colorimmunofluorescencebysinglelaserflowcytometry.JImmunolMeth170:145-157,1994.

Stainingfordetectionofapoptosis

1x106PBSAz-washedcellsfromasinglecellsUSPensionarepelletedina12X75mmculturetube.Thepelletisresuspendedin1mlof1XPBSAzcontaining20micrograms/mlof7-AADandthesuspensionismixedgently.Afterapproximately20minofincubationat4°Cinthedark,thesamplescanberunontheflowcytometerintheirstainingsolution.Theyshouldbekeptcoldduringacquisitionandshouldberunwithin1haftertheadditionof7-AAD,otherwisecellsshouldbefixed.

Note:itispossIBLetofixcellsstainedwith7-AADfordetectionofapoptosiswitha1%formaldehydesolutioncontaining20micrograms/mlofactinomycinD(AD,C1,e.g.,BoehringerMannheim)forbiohazardconsiderationsand/ortopreservesamplesforlateranalysisontheflowcytometer.Forprocedureseeattachedprotocol.

Thisstainingprocedureallowsthecorrelationofapoptosiswithsingleordual-colorphenotypeandtheuseofFITCand/orPEconjugatedmonoclonalantibodies.Surfaceantigenstainingisdoneaccordingtostandardmethodsbeforestainingforapoptosis.Then,theapoptosisassayisperformedasdescribedabove.

DirectStainingProcedure

1.Resuspendcellpelletfirstin50microlitersofHABforapproximately1min,thenadd50microlitersofPBSAzandtheappropriateamountofFluorochrome-conjugatedmonoclonalantibody(mAb).

2.Vortexbrieflyandincubatefor15minat4°Cinthedark.

3.Washoncewith2mlsofPBSAzbycentrifugationat250gfor5minutes.

4.Proceedwithstainingforapoptosisasdescribedabove.

IndirectStainingProcedure

1-3Processsamplesasaboveusingaworkingdilutionofunlabelledantibody.

4.Resuspendcellpelletfirstin50microlitersofHABforapproximately1min,thenadd50microlitersofaworkingdilutionofthefluorochrome-conjugatedsecondantibody.

5.Vortexbrieflyandincubatefor20minat4°Cinthedark.

6.Washoncewith2mlsofPBSAzbycentrifugationat250gfor5min.

7.Proceedwithstainingforapoptosisasdescribedabove.

Note:donotuseHABforstainingofimmunoglobulinchains.Wheneveravailable,useamonoclonalantibodyand/orareagentdirectlyconjugatedtoafluorochrometominimizeunspecificbinding.Alwaysuseisotypiccontrolsofthesameheavychainclassasyourrelevantantibodyfordeterminationofbackgroundstaining.

ProtocolfortheuseofactinomycinD(AD)onsamplesthatwerestainedwith7-AADforapoptosisandfixedinformaldehyde.

I.Materials:

1.ActinomycinD(AD,C1,e.g.,BoehringerMannheim,IN)

2.1XPBS

3.Sonicator

4.Formaldehydesolution(seeprotocolforpreparationof2%stockformaldehydesolution)

II.PreparationofADstocksolution(1mg/ml):

To1mgofADpowderadd:

50microlitersoficecoldabsoluteETOH,vortex

950microlitersof1XPBS

Sonicatetheresultingsolutionfor10minat4°C;keepthesolutionovernightintherefrigeratorat4°C,protectedfromlightbeforeusingit.

Storesolutionat4°Cprotectedfromlight.

Workingdilutionis20micrograms/ml.

III.Method:

Cellsarefirstincubatedwith7-AADforatleast20min,thentheyarespundownonceandimmediatelya1%formaldehydesolutioncontaining20microliters/mlofAD(F/AD)isaddedtothecellpellet.Cellshavetobestoredinthecoldprotectedfromlightandcanbeanalyzedapproximately30minaftertheadditionoftheF/ADsolution.CellsarerunontheflowcytometerintheF/ADsolution.Wehavestoredsamplesupto3dayswithoutanylossintheabilitytodiscriminateearlyapoptoticfromlivecellsandlateapoptoticornecroticcells.

INFORMATIONANDREFERENCESONDETECTIONOFAPOPTOTICCELLSBYFLOWCYTOMETRY

ComparedtotheclassicmethodsofDNAladderformationbygelelectrophoresisandofmorphologicexaminationbyelectronmicroscopyfordeterminationofapoptosis,flowcytometrypermitsrapidandquantitativemeasurementsonapoptoticcells.Manydifferentflowcytometricmethodsfortheassessmentofapoptosisincellshavebeendescribed(forareviewsee1);mostofthesemethodsmeasureapoptoticchangesincellsbystainingwithvariousDNAdyes,however,techniquesusingtheterminaldeoxynucleotidyltransferaseornicktranslationassayshavealsobeendeveloped(3).Someofthesestainingmethodsutilizeunfixedcells(2,4,5,7,8,9,10,11).Duetothefragilityofcellsundergoingprogrammedcelldeath,rapidmethodsthatmaintaincellsascloseaspossibletotheirnaturalstatemightbeexpectedtoprovidethemostreliableresults.Thecurrentrapid7-AADstainingmethodusesunfixedcellsandthuspermitsthedetectionofchangesinlightscatterparametersandtheircorrelationwithotherindicatorsofprogrammedcelldeath.However,onedrawbackofusinganylivestainingmethodformeasuringapoptosisisthevariabilityofdyeuptakeindifferentcellsanditspossiblechangethroughcertaintreatmentconditions.FurThermore,reagentswhichaffectmembranepermeability(e.g.calciumionophores)cannotbeusedwiththistechnique.

ManystainingmethodsforflowcytometryuseeitherfixedcellsortreatcellswithahypotonicsolutiontopermitDNAstainingbynon-vitaldyes.TheapoptoticcellswithdegradedDNAappearascellswithhypodiploidDNAcontentandarerepresentedinso-called"sub-G1"peaksonDNAhistograms(6,12).Telfordet.al.(12)showedonmurinethymocytesthatmanydifferentDNAdyesproducesimilardistributionsof"sub-G1"peaksirrespectiveoftheirbindingmodewhenthesamecellfixationmethodwasused.However,whenwetriedtoapplythehypotonicPImethodbyNicolettietal.(6)tohumanthymocytesourresultsindicatedthatuseofdissimilarsamplepreparationmethods(e.g.livestainingwithHO342vs.hypotonicPI)canleadtodramaticdifferencesintheabilitytodetectapoptoticcells.Undercertainconditions,thetreatmentofhumanthymocyteswithhypotoniccitratesolutioncontainingdetergentmaynotpermitleakageofthelowmolecularweightDNAoutofapoptoticcells;thisleakagehasbeenproposedasapre-requisitefortheformationof"sub-G1"peaks(1).Inmurinethymocytes,however,thehypotonicPIstainingmethodproducesacleardistinctionbetweenliveandapoptoticcells(6).

Recently,ithasbeenpostulatedthatthestabilityandthekineticsofintermediatecelldeathstagesmaydeterminetheresistanceofaparticularcelltypetoDNAdegradation.Consequently,thevisibilityof"sub-G1"peaksbyflowcytometryandalsotheformationofcharacteristicDNAladdersonagarosegelsmightbeafunctionofindividualcellularhomeostasis.Theabsenceofa"sub-G1"peakonaDNAhistogramshouldnotconstituteproofofnoapoptosis(1).Conversely,ithasalsobeenstatedthatthemereappearanceofahypodiploidDNApeakshouldnotbetakenasdefiniteevidenceforthepresenceofanapoptoticcellpopulationwithoutothersupportinginformation(7).Flowcytometricfindingsinaparticularcelltypeexposedtoacertainstimulusmustthereforebealwaysverifiedwithothernon-flowcytometricmethods.Recently,rapidflowcytometricstainingmethodsthatuseAnnexinVfordetectionofphosphatidylserineexposureonthecellsurfaceasaMarkerofapoptosishavebecomecommerciallyavailable.Forthisstainingmethoditisessentialtoaddadeadcelldiscriminationdyelikepropidiumiodideor7-amino-actinomycinDtothestainedcells,becauselateapoptoticornecroticcellsalsoexpressphosphatidylserineandhavetobedistinguishedfromtheearlyapoptoticcellsbyfluorescence(13).ThenewestflowcytometricassaysmeasureCaspase-3activity,anearlymarkerofcellsundergoingapoptosisandkitsforperformingthisassaysarecommerciallyavailable(14).

Pleasekeepinmindthatnotallmethodsfordetectionofapoptosisincellsmaybeequallysensitiveandtechniquesmustbeassessedcriticallywithrespecttotheirapplicabilitytoaparticularcelltypeorsystem.

免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
相关文章